Ptesculentoside, a novel norsesquiterpene glucoside from the Australian bracken fern Pteridium esculentum
摘要:
A novel norsesquiterpene glucoside ptesculentoside has been isolated from the Australian bracken pteridium esculentum, together with the known bracken carcinogen ptaquiloside and lesser amounts of caudatoside. The structure of ptesculentoside is determined by analysis of 1D and 2D NMR spectra, and via its conversion into previously known pterosin G. Crown Copyright (C) 2010 Published by Elsevier Ltd. All rights reserved.
USE OF PTEROSIN COMPOUNDS FOR TREATING DIABETES AND OBESITY
申请人:Hsu Feng-Lin
公开号:US20100190732A1
公开(公告)日:2010-07-29
This invention relates to the use of pterosin compounds of formula I for treating diabetes including type I and type II. Also disclosed is the use of the pterosin compounds for treating obesity.
Ptesculentoside, a novel norsesquiterpene glucoside from the Australian bracken fern Pteridium esculentum
作者:Mary T. Fletcher、Patrica Y. Hayes、Michael J. Somerville、James J. De Voss
DOI:10.1016/j.tetlet.2010.02.032
日期:2010.4
A novel norsesquiterpene glucoside ptesculentoside has been isolated from the Australian bracken pteridium esculentum, together with the known bracken carcinogen ptaquiloside and lesser amounts of caudatoside. The structure of ptesculentoside is determined by analysis of 1D and 2D NMR spectra, and via its conversion into previously known pterosin G. Crown Copyright (C) 2010 Published by Elsevier Ltd. All rights reserved.